TSE:SVA Sernova (SVA) Stock Price, News & Analysis → The Key to this $10 Trillion Tech Boom (From Porter & Company) (Ad) Free SVA Stock Alerts C$0.36 +0.01 (+1.41%) (As of 09:50 AM ET) Add Compare Share Share Today's RangeC$0.36▼C$0.3650-Day RangeC$0.28▼C$0.5252-Week RangeC$0.27▼C$1.10Volume2,074 shsAverage Volume153,732 shsMarket CapitalizationC$109.23 millionP/E RatioN/ADividend Yield7.86%Price TargetC$1.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlines Get Sernova alerts: Email Address Sernova MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside322.5% UpsideC$1.50 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment-0.13Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.67 out of 5 stars 3.0 Analyst's Opinion Consensus RatingSernova has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageSernova has only been the subject of 1 research reports in the past 90 days.Read more about Sernova's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for SVA. Previous Next 1.7 Dividend Strength Dividend LeadershipSernova is a leading dividend payer. It pays a dividend yield of 7.86%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthSernova does not have a long track record of dividend growth.Read more about Sernova's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SVA. Previous Next 1.0 News and Social Media Coverage News SentimentSernova has a news sentiment score of -0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Sernova this week, compared to 0 articles on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sernova insiders have not sold or bought any company stock.Percentage Held by Insiders12.71% of the stock of Sernova is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 0.05% of the stock of Sernova is held by institutions.Read more about Sernova's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Sernova is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sernova is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSernova has a P/B Ratio of 35.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyThe Key to this $10 Trillion Tech BoomPresident Biden has just approved $2.6 billion for this breakthrough technology… And it has nothing to do with artificial intelligence, cryptocurrency, or the blockchain.To get all the details of this new tech – click here now. About Sernova Stock (TSE:SVA)Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.Read More SVA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SVA Stock News HeadlinesMay 28, 2024 | finance.yahoo.comSernova Appoints Jonathan Rigby to its Board of DirectorsApril 25, 2024 | finance.yahoo.comSernova Provides Organizational UpdateApril 2, 2024 | theglobeandmail.comSernova Provides Positive Clinical and Platform Portfolio UpdateMarch 14, 2024 | theglobeandmail.comNYC Arts Organization, Autumn Salon, Announces Next Concert 'Music Box'February 20, 2024 | finance.yahoo.comSernova Corp (PSH.MU)February 17, 2024 | morningstar.comSernova Corp SVAJanuary 9, 2024 | finance.yahoo.comWe Think Sernova (TSE:SVA) Can Afford To Drive Business GrowthNovember 27, 2023 | markets.businessinsider.comSernova Gets FDA Orphan Drug, Rare Pediatric Disease Designations For Hemophilia A ProgramNovember 27, 2023 | finance.yahoo.comSernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDAOctober 11, 2023 | finance.yahoo.comSernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA CongressOctober 4, 2023 | markets.businessinsider.comH.C. Wainwright Thinks Sernova’s Stock is Going to RecoverSeptember 29, 2023 | markets.businessinsider.comH.C. Wainwright Reaffirms Their Buy Rating on Sernova (SVA)September 14, 2023 | markets.businessinsider.comSernova (SVA) Gets a Buy Rating from Echelon Wealth PartnersSeptember 14, 2023 | finance.yahoo.comSernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22September 13, 2023 | finance.yahoo.comSernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business UpdateSeptember 5, 2023 | markets.businessinsider.comEchelon Wealth Partners Maintains Their Buy Rating on Sernova (SVA)August 4, 2023 | theglobeandmail.comClosing Bell: Sernova Corp flat on Wednesday (SVA)August 2, 2023 | finance.yahoo.comIs Sernova (TSE:SVA) In A Good Position To Invest In Growth?July 26, 2023 | finance.yahoo.comSernova Expands Leadership Team with Appointment of Modestus Obochi, Ph.D., MBA, as Chief Business OfficerMay 3, 2023 | marketwatch.comEQS-News: Sernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell ApplicationsMay 3, 2023 | finance.yahoo.comSernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell ApplicationsApril 29, 2023 | theglobeandmail.comClosing Bell: Sernova Corp up on Friday (SVA)April 21, 2023 | theglobeandmail.comClosing Bell: Sernova Corp flat on Friday (SVA)April 19, 2023 | theglobeandmail.comClosing Bell: Sernova Corp down on Tuesday (SVA)April 18, 2023 | theglobeandmail.comClosing Bell: Sernova Corp up on Monday (SVA)See More Headlines Receive SVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/18/2024Today6/13/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:SVA CUSIPN/A CIKN/A Webwww.sinovacbio.com Phone861082890088FaxN/AEmployees1,959Year FoundedN/APrice Target and Rating Average Stock Price TargetC$1.50 High Stock Price TargetC$1.50 Low Stock Price TargetC$1.50 Potential Upside/Downside+322.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-40,730,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-183.58% Return on Assets-79.96% Debt Debt-to-Equity Ratio16.55 Current Ratio1.20 Quick Ratio18.11 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.06 per share Price / Cash Flow6.15 Book ValueC$0.01 per share Price / Book35.50Miscellaneous Outstanding Shares303,410,000Free FloatN/AMarket CapC$107.71 million OptionableNot Optionable Beta1.53 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesDr. Philip M. Toleikis B.A.M.Sc., Ph.D., President, CTO, Director of Technology & DirectorMr. Christopher BarnesVice President of Investor RelationsDr. Frank Shannon M.D.Vice President of Clinical Development & Regulatory AffairsMs. Cynthia PussinenCEO & DirectorMr. Nicholas J. Rossettos CPA (Age 58)M.B.A., Interim Chief Financial Officer Mr. Douglas MaretChief Science OfficerDr. Modestus Obochi M.B.A.Ph.D., Chief Business OfficerMore ExecutivesKey CompetitorsProMetic Life SciencesTSE:PLIFennec PharmaceuticalsTSE:FRXVIVO CannabisCVE:ABCNEmblemCVE:EMCMedicenna TherapeuticsTSE:MDNAView All Competitors SVA Stock Analysis - Frequently Asked Questions Should I buy or sell Sernova stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sernova in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" SVA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SVA, but not buy additional shares or sell existing shares. View SVA analyst ratings or view top-rated stocks. What is Sernova's stock price target for 2024? 1 analysts have issued 1 year price objectives for Sernova's shares. Their SVA share price targets range from C$1.50 to C$1.50. On average, they expect the company's share price to reach C$1.50 in the next year. This suggests a possible upside of 322.5% from the stock's current price. View analysts price targets for SVA or view top-rated stocks among Wall Street analysts. How have SVA shares performed in 2024? Sernova's stock was trading at C$0.70 at the beginning of the year. Since then, SVA shares have decreased by 49.3% and is now trading at C$0.36. View the best growth stocks for 2024 here. How were Sernova's earnings last quarter? Sernova Corp. (TSE:SVA) posted its earnings results on Monday, March, 18th. The company reported ($0.03) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.03). How do I buy shares of Sernova? Shares of SVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:SVA) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sernova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.